RecruitingNot ApplicableNCT04836936

Auriculotherapy in the Treatment of Pre-Operative Anxiety

Auriculotherapy in the Treatment of Pre-Operative Anxiety - A Randomized, Prospective, Placebo-Controlled Clinical Trial


Sponsor

Jacques E. Chelly

Enrollment

60 participants

Start Date

Apr 13, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to use the validated PROMIS Emotional Distress - Anxiety - Short Form 8a and PROMIS Emotional Distress-Depression-Short Form pre-and post-intervention to establish a superior correlation between the auriculotherapy treatment and the reduction of perioperative anxiety. Subject population will include those having a partial or total nephrectomy for cancer. Drawing the role that auriculotherapy may play in reducing perioperative anxiety related requirement after surgery may also help in reducing the risk of opioid use disorders (OUD) since anxiety has been found to be a major risk factor for OUD in surgical patients. Therefore, this trial will also examine the effect of the auriculotherapy intervention in reducing opioid requirement after surgery.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Greater than 18 years of age
  • Scheduled to undergo partial or full elective nephrectomy
  • Subject is willing and able to provide informed consent
  • Anxiety score ≥ 19 and ≤ 29 on the PROMIS Emotional Distress-Anxiety-Short Form 8a.

Exclusion Criteria7

  • Opioid dependence, based on the DSM definition of Opioid Use Disorder (OUD)
  • Chronic pain condition where daily opioid use is needed
  • History of fibromyalgia
  • Anatomical malformation of ear (genetic or trauma-induced)
  • Vasculopathy of ear
  • Raynaud's disease
  • Patient Refusal

Interventions

DEVICEAuriculotherapy cryopuncture device without nitrogen gas

Auriculotherapy cryopuncture device without nitrogen gas will be administered. Application of this placebo device will be performed in the same manner as the treatment, but without the expulsion of nitrogen gas.

DEVICEAuriculotherapy cryopuncture device with nitrogen gas

Auriculotherapy cryopuncture device with nitrogen gas will be administered. The tip of the cryopuncture will be sanitized and placed on each treatment point of the ear, releasing a spurt of nitrogen gas for 2 seconds on each point (6 points total).


Locations(1)

UPMC Shadyside Hospital

Pittsburgh, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04836936


Related Trials